Изучение влияния различных диетических рационов на показатели цитокинового статуса и апоптоза у больных сахарным диабетом 2 типа



страница10/10
Дата23.04.2016
Размер0.92 Mb.
ТипДиссертация
1   2   3   4   5   6   7   8   9   10

Low insulin–like growth factor–II levels predict weight gain in normal weight subjects with type 2 diabetes / A.H. Heald, L. Kärvestedt, S.G. Anderson, J. McLaughlin, et al. // Am J Med. – 2006. – V.119. – N2. – P.167–15.

  • Low–fat versus low–carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial / U. Bradley, M. Spence, C.H. Courtney, M.C. McKinley, et al. // Diabetes. – 2009. –V.58. – N12. – P.2741–48.

  • Macronutrient intake and glycemic control in a population–based sample of American Indians with diabetes: the Strong Heart Study / X. Jiaqiong, E. Sigal, M.L. Catherine, V.H. Barbara, et al. // Am. J. Clin. Nutr. – 2007. – V.86. – P.480–487.

  • Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature / M.L. Wheeler, S.A. Dunbar, L.M. Jaacks, W. Karmally, et al. // Diabetes Care. – 2012. – V.35. – N2. – P.434–45.

  • Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes / E.A. Nyenwe, T.W. Jerkins, G.E. Umpierrez, A.E. Ki // Metab Clin and Experim. – 2011. – V.60. – P.1–23.

  • Mandrup–Poulsen T. AIDA study group.Interleukin–1 antagonists for diabetes / T. Mandrup–Poulsen // Expert Opin Investig Drugs. – 2013. – V.22. – N8. – P.965–79.

  • McCarthy M.I. Genome–wide association studies in type 2 diabetes / M.I. McCarthy, E. Zeggini // Curr Diab Rep. – 2009. – V.9. – N2. – P.164–71.

  • McKenzie M.D. Proapoptotic BH3–Only Protein Bid Is Essential For Death Receptor–Induced Apoptosis of Pancreatic β–Cells / MD McKenzie, EM. Carrington, T Kaufmann // Diabetes. – 2008. – V.57. – P.1284–1292.

  • McKillop A.M. Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine / A.M. McKillop, P.R. Flatt // Diabetes Care. – 2011. – V.34. – N12. – P.2624–30.

  • New percentage body fat prediction equations for Japanese females / M. Kagawa, C. Kuroiwa, K. Uenishi et al. // J Physiol Anthropol. – 2007. – V.26. – P.23–29.

  • Normal–weight obese syndrome: early inflammation? / A. De Lorenzo, V. Del Gobbo, M.G. Premrov, M. Bigioni, et al. // American Journal of Clinical Nutrition. – 2007. – V.85. – N1. – P.40–45.

  • Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance / I. Abete, A. Astrup, J.A. Martínez, I. Thorsdottir, et al. // Nutr Rev. – 2010. – V.68. – N4. – P.214–231.

  • Olefsky J.M. Macrophages, inflammation, and insulin resistance / J.M. Olefsky, C.K. Glass // Annual Review of Physiology. – 2009. – V.72. – P.219–246.

  • Page K.A. Interventions to Preserve Beta–Cell Function in the Management and Prevention of Type 2 Diabetes / K.A. Page, T. Reisman // Curr Diab Rep. – 2013. – V.13. – N 2. – P.252-60.

  • Pancreatic islet inflammation in Type 2 diabetes: from alpha to beta cell compensation to dysfunction / J.A Ehses, H. Ellingsgaard, M. Boni–Schnetzler, M.Y. Donath // Arch Physiol Biochem. – 2009. – V.115. – P.240–247.

  • Petzke K.J. Beyond the role of dietary protein and amino acids in the prevention of diet–induced obesity / K.J. Petzke, A. Freudenberg, S. Klaus // Int J Mol Sci. – 2014. – V.15. – N1. – P.1374–91.

  • Plasma vitamin C level, fruit and vegetable consumption, and the risk of new–onset type 2 diabetes mellitus: the European prospective investigation of cancer––Norfolk prospective study / A.H. Harding, N.J. Wareham, S.A. Bingham, K. Khaw, et al. // Arch Intern Med. – 2008. – V.168. – N14. – P.1493–9.

  • Poh Z.X. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus / Z.X. Poh, K.P. Goh // Endocr Metab Immune Disord Drug Targets. – 2009. – V.9. – N4. – P.392–8.

  • Postprandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese Type 2 diabetic patients / T.Shiraiwa, H. Kaneto, T.Miyatsuka et al. // Biochem. Biophys. Res. Commun. – 2005. – V.336. – P.339–345.

  • Pradhan A. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders / A. Pradhan // Nutr Rev. – 2007. – V.65. – N12 (Pt 2). – P.S152–6.

  • Profile of proinflammatory cytokines in type 1 diabetes mellitus / I.H. Kyiak, N.V. Fartushok, I.I. Onyshchuk, I.M. Fedevych, et al. // Fiziol Zh. – 2012. – V.58. – N5. – P.65–9.

  • Pro–inflammatory cytokines related to severity and mortality in type 2 diabetes patients with soft tissue infection / G. García–Elorriaga, M. Padilla–Reyes, F. Cruz–Olivo, J.L. Fuentes–Allen, et al. // Rev Med Inst Mex Seguro Soc. – 2012. – V.50. – N3. – P.237–41.

  • Protein–caloric food restriction affects insulin–like growth factor system in fetal Wistar rat / M.A. Martín, P. Serradas, S. Ramos, E. Fernández, et al. // Endocrinology. – 2005. – V.146. – N3. – P.1364–71.

  • Qi Q. Genetics of type 2 diabetes in European populations / Q. Qi, F.B. Hu // J Diabetes. – 2012. – V.4. – N3. – P.203–12.

  • Ramos–Nino M.E. The role of chronic inflammation in obesity–associated cancers / M.E. Ramos–Nino // ISRN Oncol. – 2013:697521.

  • Recent advances in the relationship between obesity, inflammation, and insulin resistance / J.P. Bastard, M. Maachi, C. Lagathu, et al. // European Cytokine Network. – 2006. – V.17. – N1. – P.4–12.

  • Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta–analysis / M. Cardona–Morrell, L. Rychetnik, S.L. Morrell, P.T. Espinel, et al. // BMC Public Health. – 2010. – N10. – P.653.

  • Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin–4 / Y.H. Chang, K.T. Ho, S.H. Lu, C.N. Huang, et al. // Int J Obes (Lond) . – 2012. – V.36. – N7. – P.993–8.

  • Restricted–carbohydrate diets in patients with type 2 diabetes: a meta–analysis / J.K. Kirk, D.E. Graves, T.E. Craven, E.W. Lipkin, et al. // J Am Diet Assoc. – 2008. – V.108. – N1. – P.91–100.

  • Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patientswith type 2 diabetes mellitus / D.A. De Luis, R. Aller, O. Izaola, M. Gonzalez Sagrado, et al. // Eur Rev Med Pharmacol Sci. – 2013. – V.17. – N15. – P.2059–64.

  • Role of postprandial hyperglycaemia in cardiovascular disease in diabetes / S.I. Yamagishi, K. Nakamura, T. Matsui, S.I. Ueda, et al. // Int J Clin Pract. – 2007. – V.61. – P.83–87.

  • Rondinone C.M. Adipocyte–derived hormones, cytokines, and mediators / C.M. Rondinone // Endocrine. – 2006. – V.29. – N1. – P.81–90.

  • Roumen C. Lifestyle intervention for prevention of diabetes: determinants of success for future implementation / C. Roumen, E.E. Blaak, E. Corpeleijn // Nutr Rev. – 2009. – V.67. – N3. – P.132–46.

  • Ruan W. Insulin–like growth factor binding protein: a possible marker for the metabolic syndrome? / W. Ruan, M. Lai // Acta Diabetol. – 2010. – V.47. – N1. – P.5–14.

  • Saligram S. Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control / S. Saligram, E.J. Williams, M.G. Masding // Indian J Endocrinol Metab. – 2012. – V.16. – N6. – P.1012–4.

  • Sattar N. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? / N. Sattar, S.G. Wannamethee, N.G. Forouhi // Diabetologia. – 2008. – V.51. – P.926–940.

  • Schwingshackl L. Comparison of effects of long–term low–fat vs high–fat diets on blood lipid levels in overweight or obese patients: a systematic review and meta–analysis / L. Schwingshackl, G. Hoffmann // J Acad Nutr Diet. – 2013. – V.113. – N12. – P.1640–61.

  • Sell H. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation? / H. Sell, J. Eckel // Proc Nutr Soc. – 2009. – V.68. – N4. – P.378–84.

  • Serum hyperglycemia might be not related to fat composition of diet and vegetable composition of diet might improve sugar control in taiwanese diabetic subjects / Y.C. Hou, Y.L. Chang, S.C. Kuo, C.F. Chiang, et al. // Int J Med Sci. – 2014. – V.11. – N5. – P.515–21.

  • Serum zinc and magnesium in type–2 diabetic patients / N. Masood, G.H. Baloch, R.A. Ghori, I.A. Memon, et al. // J Coll Physicians Surg Pak. – 2009. – V.19. – N8. – P.483–6.

  • Serum zinc and magnesium level in newly diagnosed type–2 diabetic subjects / S. Ferdousi, A.R. Mia, L. Mahzabeen, R.K. Nath, et al. // Mymensingh Med J. – 2013. – V.22. – N3. – P.552–6.

  • Shanthi B. Effect of iron deficiency on glycation of haemoglobin in nondiabetics / B. Shanthi, C. Revathy, A.J. Manjula Devi // J Clin Diagn Res. – 2013. – V.7. – N1. – P.15–7.

  • Sharafetdinov Kh.Kh. Methodology of use of an enteral nutrition formulas in diet therapy of patients with type 2 diabetes / Kh.Kh. Sharafetdinov, V.A. Meshcheriakova, O.A. Plotnikova // Vopr Pitan. – 2005. – V.74. – N4. – P.17–22.

  • Shaw J.E. Diabetes / J.E. Shaw, R.A. Sicree, P.Z. Zimmet // Res Clin Pract. – 2010. – V.87. – P.4–14.

  • Shoelson S.E. Inflammation and insulin resistance / S.E. Shoelson, J. Lee, A.B. Goldfine // Journal of Clinical Investigation. – 2006. – V.116. – N7. – P.1793–1801.

  • Signaling molecules involved in lipid–induced pancreatic Beta–cell dysfunction / S. Shao, Y. Yang, G. Yuan, M. Zhang, et al. // DNA Cell Biol. – 2013. – V.32. – N2. – P.41–9.

  • Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes–specific enteral formulas / K.Van Schoonbeek, M. Lansink, K.M. Van Laere, J.M. Senden, et al. // Diabetes Educ. – 2009. – V.35. – N4. – P.631–40.

  • Speaker K.J. Interleukin–1 beta: a potential link between stress and the development of visceral obesity / K.J. Speaker, M. Fleshner // BMC Physiol. – 2012. – V.12. – P.8.

  • Steyn N.P. Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Diabetes and health". Nutrition interventions for the prevention of type 2 diabetes / N.P. Steyn, E.V. Lambert, H. Tabana // Proc Nutr Soc. – 2009. – V.68. – N1. – P.55–70.

  • Strasser A. The many roles of FAS receptor signaling in the immune system / A. Strasser, P. J Jost, S. Nagata // Immunity. – 2009. – V.30. – N2. – P. 180–192.

  • Supplementation of coenzyme Q10 and alpha–tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats / C.M. Sena, E. Nunes, A. Gomes, M.S. Santos, et al. // Nutr Res. – 2008. – V.28. – N2. – P.113–21.

  • Susan E. Apoptosis: A Review of Programmed Cell Death / E. Susan // Toxicol Pathol. – 2007. – V.35. – N4. – P.495–516.

  • Sustained IL–1alpha, IL–4, and IL–6 elevations following correction of hyperglycemia in children with type 1diabetes mellitus / J.S. Rosa, R.L. Flores, S.R. Oliver, A.M. Pontello, et al. // Pediatr Diabetes. – 2008. – V.9. – N1. – P.9–16.

  • Terry J. SmithInsulin–Like Growth Factor–I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases? / J. Terry // Pharmacol Rev. – 2010. – V.62. – N2. – P.199–236.

  • The effect of different nutritional feeds on the postprandial glucose response in healthy volunteers and patients with type II diabetes / Z. Hofman, J.D. Van Drunen, C. De Later, H. Kuipers // Eur J Clin Nutr. – 2004. – V.58. – N11. – P.1553–6.

  • The effect of enteral nutritional suspension (diabetes) (TPF–DM) on blood glucose, serum insulin and lipids in patients with type 2 diabetes / Y.X. Li, S.H. Pan, J.B. Zeng, K. Yu, et al. // Zhonghua Nei Ke Za Zhi. – 2007. – V.46. – N3. – P.193–6.

  • The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome / P.J. Manning, W.H. Sutherland, S.M. Williams, R.J. Walker, et al. // Nutr Metab Cardiovasc Dis. – 2013. – V.23. – N6. – P.543–9.

  • The emerging role of adipokines as mediators of inflammation and immune responses / F. Lago, C. Dieguez, J. Comez–Reino, O. Gualillo // Cytokone Growth Factor Rev. – 2008. – N18 (3–4). – P. 313–325.

  • The role of diet in the prevention of type 2 diabetes / J. Salas–Salvadó, M.Á. Martinez–González, M. Bulló, E. Ros // Nutr Metab Cardiovasc Dis. – 2011. – V.21. – P.32–48.

  • Tilg H. Adipocytokines: mediators linking adipose tissue, inflammation and immunity / H. Tilg, A.R. Moschen // Nature Reviews Immunology. – 2006. – V.6. – N10. – P.772–783.

  • TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue—influence of BMI and adipose distribution / M. Good, F.M. Newell, L.M. Haupt, J.P. Whitehead, et al. // Diabetes and Vascular Disease Research. – 2006. – V.3. – N1.–P.26–33.

  • Townsend K. Brown adipose tissue: Recent insights into development, metabolic function and therapeutic potential / K. Townsend, Y.H. Tseng // Adipocyte. – 2012. – V.1. – N1. – P.13–24.

  • Trayhurn P. Adipokines: inflammation and the pleiotropic role of white adipose tissue / P. Trayhurn, I.S. Wood // Br J Nutr. – 2004. – V.92. – P.347–55.

  • Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity / P. Trayhurn // Physiol Rev. – 2013. – V.93. – N1. – P.1–21.

  • Trayhurn P. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? / P. Trayhurn, B. Wang, I.S. Wood // Br J Nutr. – 2008. – V.100. – N2. – P.227–35.

  • Tumor necrosis factor alpha –238G/A (rs 361525) gene polymorphism predicts progression to type–2 diabetes in an Eastern Indian population with prediabetes / D. Dutta, S. Choudhuri, S.A. Mondal, I. Maisnam, et al. // Diabetes Res Clin Pract. – 2013. – V. 99. – N 3. – P.37-41.

  • Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention / A. Badawi, K. Amira, H. Pierre, E.C. David, et al. // Diabetes Metab Syndr Obes. – 2010. – V.3. – P.173–186.

  • Type 2–diabetes is associated with elevated levels of TNF–alpha, IL–6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross–sectional study / S. Mirza, M. Hossain, C. Mathews, P. Martinez, et al. // Cytokine. – 2012. – V.57. – N1. – P.136–42.

  • Van Haeften T.W. Insulin–like growth factors and pancreas beta cells / T.W. Van Haeften, T.B. Twickler // Eur J Clin Invest. – 2004. –V.34. – N4. – P.249–55.

  • Vaquerizo A.C. Spanish Society of Intensive Care Medicine and Coronary Units–Spanish Society of Parenteral and EnteralNutrition (SEMICYUC–SENPE). Guidelines for specialized nutritional and metabolic support in the critically–ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units–Spanish Society of Parenteral and EnteralNutrition (SEMICYUC–SENPE): hyperglycemia and diabetes mellitus / A.C. Vaquerizo, C.T. Grau, D.M. Juan // Med Intensiva. – 2011. – V.35. – N1. – P.48–52.

  • Vetter M.L. Nutritional management of type 2 diabetes mellitus and obesity and pharmacologic therapies to facilitate weight loss / M.L. Vetter, A. Amaro, S. Volger // Postgrad Med. – 2014. – V.126. – N1. – P.139–52.

  • Virtue S. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome – an allostatic perspective / S. Virtue, A. Vidal–Puig // Biochim Biophys Acta. – 2010. – V.1801. – N3. – P.338–49.

  • Visceral and subcutaneous adipose tissue volumes are cross–sectionally related to markers of inflammation and oxidative stress. The Framingham Heart Study / J.B. Meigs, I. Lipinska, S. Kathiresan, et al. // Circulation. – 2007. – V.116. – N11. – P.1234–1241.

  • Visceral and subcutaneous adipose tissue volumes are cross–sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study / K.M. Pou, J.M. Massaro, U. Hoffmann, R.S. Vasan, et al. // Circulation. – 2007. – V.116. – N11. – P.1234–41.

  • Waist circumference is an independent predictor of insulin resistance in black and white youths / S. Lee, F. Bacha, N. Gungor, S.A. Arslanian // J Pediatr. – 2006. – V.148. – N2. – P.188–94.

  • Waist circumference, dual–energy X–ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra–abdominal fat area on detecting metabolic risk factors in obese women / K. Lee, S. Lee, Y.J. Kim, Y.J. Kim // Nutrition. – 2008. – N24 (7–8). – P.625–31.

  • Weickert M.O. Nutritional modulation of insulin resistance / M.O. Weickert // Scientifica (Cairo). – 2012:424780.

  • Weir G.C. Five stages of evolving beta–cell dysfunction during progression to diabetes / G.C Weir, S. Bonner–Weir // Diabetes. – 2004. – V.53 (Suppl. 3. – P.16–21.

  • Wellen K.E. Inflammation, stress, and diabetes / K.E. Wellen, G.S. Hotamisligil // J Clin Invest. – 2005. –V.115. – N5. – P.1111–9.

  • Wien M. A randomized controlled trial to evaluate the effect of incorporating peanuts into an American Diabetes Association meal plan on the nutrient profile of the total diet and cardiometabolic parameters of adults with type 2 diabetes / M. Wien, K. Oda, J. Sabaté // Nutr J. – 2014. – V.13. –P.10.

  • Wilding J.P. The importance of free fatty acids in the development of type 2 diabetes / J.P. Wilding // Diabet Med. – 2007. –V. 24. – P.934–945.

  • Wilson N.S. Death receptor signal transducers: nodes of coordination in immune signalimg networks / N.S. Wilson, V. Dixit, A. Ashkenazi // Nat. Immunol. – 2009. – V.10. – P.348–335.

  • Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity / B.E. Wisse // J Am Soc Nephrol. – 2004. – V.15. – P.2792–80.

  • Xu F. Abnormal Cell Responses and Role of TNF–α in Impaired Diabetic Wound Healing / F. Xu, C. Zhang, D.T. Graves // Biomed Res Int. – 2013:754802.

  • Zimmet P. Preventing diabetic complications: a primary care perspective / P. Zimmet // Diabetes Res Clin Pract. – 2009. – V.84. – N2. – P.107–16.

  • α–Tocopherol status and expression of α–tocopherol transfer protein in type 2 diabetic Goto–Kakizaki rats / H. Miyazaki, K. Takitani, M. Koh, R. Takaya, et al. // J Nutr Sci Vitaminol (Tokyo). – 2013. – V.59. – N1. – P.64–8.

  • β–cell loss and β–cell apoptosis in human type 2 diabetes are related to islet amyloid deposition / C.A. Jurgens, M.N. Toukatly, C.L. Fligner, et al. // Am J Pathol. – 2011. – V.178. – P.2632–2640.

  • 303. β–cell loss and β–cell apoptosis in human type 2 diabetes are related to islet amyloid deposition / C.A. Jurgens, M.N. Toukatly, C.L. Fligner, et al. // Am J Pathol. – 2011. – V.178. – P.2632–2640.

    Каталог: files
    files -> Вопросы сертификационного экзамена для врачей по специальности «лфк и спортивная медицина»
    files -> Рабочая программа составлена в соответствии с Требованиями к содержанию дополнительных профессиональных образовательных программ
    files -> Рабочая программа дисциплины Лечебная физическая культура и массаж Направление подготовки 050100 Педагогическое образование
    files -> Лечебная физкультура
    files -> К рабочей программе дисциплины «Лечебная физкультура и спортивная медицина»
    files -> Рабочая программа учебной дисциплины «медицинская реабилитация» цикла Медицинская реабилитация для специальности 310501 «Лечебное дело» по специализации 310501 «Лечебное дело»
    files -> Лекции (час) Семинары (час) Самост работа Всего баллов Модуль 1
    files -> Влияние мобильного телефона на здоровье человека


    Поделитесь с Вашими друзьями:
  • 1   2   3   4   5   6   7   8   9   10


    База данных защищена авторским правом ©zodorov.ru 2017
    обратиться к администрации

        Главная страница